CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (163)	5/12/1998 4:01:00 PM
From: Jay Lowe	Read Replies (2) of 586

Another point ... CYPB is reported as follows (Gruss quote): " ... Cypress has instituted an ongoing R&D program to elucidate the mechanism of action of the device (1) . We believe the decision by management to institute this important work will eventually clarify the mechanism of action, thereby facilitating the product's acceptance. Leading academic researchers, directed by Dr. Gerald Nepom at the Virginia Mason Research Institute and by Eric Sasso of the University of Washington, are performing this work." (1) refers to the "Cypress Bioscience, Inc. - Scientific Sub-Protocol Program" I suggest you ask for a copy of the Scientific Protocol. I suggest you also ask to interview Nepom and Sasso. I am not qualified to parse whatever input I might get from these folks, but it looks like maybe you are ... and this would be a valuable contribution! BTW, what's your background, biochemist, MD, ... ??? I think a good technical report would be an EXCELLENT resource ... and if CYPB happened to differ with your findings that would nicely serve to focus some attention on the issues. So ... go for it! (and if CYPB won't play, I'll definitely be calling to ask why not!)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next